Report cover image

Omega 3 Supplements Market Report and Forecast 2025-2034

Published Aug 11, 2025
Length 153 Pages
SKU # EMAR20434428

Description

The global omega 3 supplements market stood at a value of around USD 7.15 Billion in 2024. The market is further expected to grow at a CAGR of 8.50% in the forecast period of 2025-2034 to attain a value of around USD 16.17 Billion by 2034.

Rising Demand for Fish Oil and Algae Oil to Bolster the Growth of the Omega 3 Supplements Industry

Based on source, the fish oil segment accounts for the largest share in the market and is anticipated to maintain its dominance in the forecast period as well. This can be attributed to the various benefits offered by fish oil. Fish oil supplements can be consumed regularly, which can lead to the reduction of blood triglycerides, relieve inflammation, and help tackle various problems, including infertility. Over the forecast period, the population explosion is likely to propel the demand for fish oil as it contains omega-3 fatty acids in concentrated form. Meanwhile, the algae oil segment is anticipated to attain a significant growth rate in the forecast period owing to the rising inclination of consumers towards plant-based alternatives and the growing trend of veganism.

North America Accounts for a Significant Share in the Market

North America accounts for a significant share in the market and is anticipated to attain a considerable growth rate in the forecast period owing to the increasing health consciousness among consumers. The increased efforts by organisations like the American Heart Association towards spreading awareness about the benefits of omega-3 consumption to combat health issues like obesity, heart-related disorders, and depression are aiding the market. In addition, the growing prevalence of coronary heart diseases in the United States is likely to propel the demand for omega 3 supplements in the forecast period.

Omega 3 Supplements: Market Segmentation

Omega 3 supplement is defined as a dietary supplement that contains omega 3 fatty acids. The supplement comes with a number of health benefits and can be consumed in the form of tablets, capsules, and pills, among others.

Based on source, the market is divided into:
  • Fish Oil
  • Krill Oil
  • Algae Oil
  • Others
The various forms of omega 3 supplements include:
  • Tablets
  • Capsules
  • Soft Gels
  • Others
On the basis of functionality, the market is segmented into:
  • Cardiovascular Health
  • Brain, Nervous System, and Mental Health
  • Eye Diseases
  • Diabetes
  • Others
The significant end users of omega 3 supplements are:
  • Adults
  • Geriatric
  • Pregnant Women
  • Children
  • Infants
The major distribution channels of the product include:
  • OTC
  • Prescribed
Based on region, the market is divided into:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Increasing Health Concerns and the Rising Cases of Chronic Diseases to Boost the Growth of the Omega 3 Supplements Industry

The global omega 3 supplements industry is driven by the increasing health consciousness among consumers, which has enhanced the demand for dietary supplements globally. In addition, the growing prevalence of chronic diseases such as strokes, arthritis, cancer, and coronary heart diseases especially among geriatrics and adults is also aiding the market. Among the end users, the geriatric population is anticipated to account for a significant share owing to the rising cases of age-related macular degeneration (AMD) that may get worse over the age of 60. AMD can be effectively countered with omega 3 supplements, which is likely to propel the demand for the product in the forecast period.

Key Industry Players in the Global Omega 3 Supplements Market

The report gives a detailed analysis of the following key players in the global omega 3 supplements market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
  • NutriGold Inc.
  • Pharma Nord B.V.
  • Luhua Biomarine (Shandong) Co., Ltd.
  • Aker BioMarine ASA
  • KD Pharma Group SA
  • Nordic Naturals, Inc.
  • Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Table of Contents

153 Pages
1 Executive Summary
1.1 Market Size 2024-2025
1.2 Market Growth 2025(F)-2034(F)
1.3 Key Demand Drivers
1.4 Key Players and Competitive Structure
1.5 Industry Best Practices
1.6 Recent Trends and Developments
1.7 Industry Outlook
2 Market Overview and Stakeholder Insights
2.1 Market Trends
2.2 Key Verticals
2.3 Key Regions
2.4 Supplier Power
2.5 Buyer Power
2.6 Key Market Opportunities and Risks
2.7 Key Initiatives by Stakeholders
3 Economic Summary
3.1 GDP Outlook
3.2 GDP Per Capita Growth
3.3 Inflation Trends
3.4 Democracy Index
3.5 Gross Public Debt Ratios
3.6 Balance of Payment (BoP) Position
3.7 Population Outlook
3.8 Urbanisation Trends
4 Country Risk Profiles
4.1 Country Risk
4.2 Business Climate
5 Global Omega 3 Supplements Market Analysis
5.1 Key Industry Highlights
5.2 Global Omega 3 Supplements Historical Market (2018-2024)
5.3 Global Omega 3 Supplements Market Forecast (2025-2034)
5.4 Global Omega 3 Supplements Market by Source
5.4.1 Fish Oil
5.4.1.1 Historical Trend (2018-2024)
5.4.1.2 Forecast Trend (2025-2034)
5.4.2 Krill Oil
5.4.2.1 Historical Trend (2018-2024)
5.4.2.2 Forecast Trend (2025-2034)
5.4.3 Algae Oil
5.4.3.1 Historical Trend (2018-2024)
5.4.3.2 Forecast Trend (2025-2034)
5.4.4 Others
5.5 Global Omega 3 Supplements Market by Form
5.5.1 Tablets
5.5.1.1 Historical Trend (2018-2024)
5.5.1.2 Forecast Trend (2025-2034)
5.5.2 Capsules
5.5.2.1 Historical Trend (2018-2024)
5.5.2.2 Forecast Trend (2025-2034)
5.5.3 Soft Gels
5.5.3.1 Historical Trend (2018-2024)
5.5.3.2 Forecast Trend (2025-2034)
5.5.4 Others
5.6 Global Omega 3 Supplements Market by Functionality
5.6.1 Cardiovascular Health
5.6.1.1 Historical Trend (2018-2024)
5.6.1.2 Forecast Trend (2025-2034)
5.6.2 Brain, Nervous System, and Mental Health
5.6.2.1 Historical Trend (2018-2024)
5.6.2.2 Forecast Trend (2025-2034)
5.6.3 Eye Diseases
5.6.3.1 Historical Trend (2018-2024)
5.6.3.2 Forecast Trend (2025-2034)
5.6.4 Diabetes
5.6.4.1 Historical Trend (2018-2024)
5.6.4.2 Forecast Trend (2025-2034)
5.6.5 Others
5.7 Global Omega 3 Supplements Market by End User
5.7.1 Adults
5.7.1.1 Historical Trend (2018-2024)
5.7.1.2 Forecast Trend (2025-2034)
5.7.2 Geriatric
5.7.2.1 Historical Trend (2018-2024)
5.7.2.2 Forecast Trend (2025-2034)
5.7.3 Pregnant Women
5.7.3.1 Historical Trend (2018-2024)
5.7.3.2 Forecast Trend (2025-2034)
5.7.4 Children
5.7.4.1 Historical Trend (2018-2024)
5.7.4.2 Forecast Trend (2025-2034)
5.7.5 Infants
5.7.5.1 Historical Trend (2018-2024)
5.7.5.2 Forecast Trend (2025-2034)
5.8 Global Omega 3 Supplements Market by Distribution Channel
5.8.1 OTC
5.8.1.1 Historical Trend (2018-2024)
5.8.1.2 Forecast Trend (2025-2034)
5.8.2 Prescribed
5.8.2.1 Historical Trend (2018-2024)
5.8.2.2 Forecast Trend (2025-2034)
5.9 Global Omega 3 Supplements Market by Region
5.9.1 North America
5.9.1.1 Historical Trend (2018-2024)
5.9.1.2 Forecast Trend (2025-2034)
5.9.2 Europe
5.9.2.1 Historical Trend (2018-2024)
5.9.2.2 Forecast Trend (2025-2034)
5.9.3 Asia Pacific
5.9.3.1 Historical Trend (2018-2024)
5.9.3.2 Forecast Trend (2025-2034)
5.9.4 Latin America
5.9.4.1 Historical Trend (2018-2024)
5.9.4.2 Forecast Trend (2025-2034)
5.9.5 Middle East and Africa
5.9.5.1 Historical Trend (2018-2024)
5.9.5.2 Forecast Trend (2025-2034)
6 North America Omega 3 Supplements Market Analysis
6.1 United States of America
6.1.1 Historical Trend (2018-2024)
6.1.2 Forecast Trend (2025-2034)
6.2 Canada
6.2.1 Historical Trend (2018-2024)
6.2.2 Forecast Trend (2025-2034)
7 Europe Omega 3 Supplements Market Analysis
7.1 United Kingdom
7.1.1 Historical Trend (2018-2024)
7.1.2 Forecast Trend (2025-2034)
7.2 Germany
7.2.1 Historical Trend (2018-2024)
7.2.2 Forecast Trend (2025-2034)
7.3 France
7.3.1 Historical Trend (2018-2024)
7.3.2 Forecast Trend (2025-2034)
7.4 Italy
7.4.1 Historical Trend (2018-2024)
7.4.2 Forecast Trend (2025-2034)
7.5 Others
8 Asia Pacific Omega 3 Supplements Market Analysis
8.1 China
8.1.1 Historical Trend (2018-2024)
8.1.2 Forecast Trend (2025-2034)
8.2 Japan
8.2.1 Historical Trend (2018-2024)
8.2.2 Forecast Trend (2025-2034)
8.3 India
8.3.1 Historical Trend (2018-2024)
8.3.2 Forecast Trend (2025-2034)
8.4 ASEAN
8.4.1 Historical Trend (2018-2024)
8.4.2 Forecast Trend (2025-2034)
8.5 Australia
8.5.1 Historical Trend (2018-2024)
8.5.2 Forecast Trend (2025-2034)
8.6 Others
9 Latin America Omega 3 Supplements Market Analysis
9.1 Brazil
9.1.1 Historical Trend (2018-2024)
9.1.2 Forecast Trend (2025-2034)
9.2 Argentina
9.2.1 Historical Trend (2018-2024)
9.2.2 Forecast Trend (2025-2034)
9.3 Mexico
9.3.1 Historical Trend (2018-2024)
9.3.2 Forecast Trend (2025-2034)
9.4 Others
10 Middle East and Africa Omega 3 Supplements Market Analysis
10.1 Saudi Arabia
10.1.1 Historical Trend (2018-2024)
10.1.2 Forecast Trend (2025-2034)
10.2 United Arab Emirates
10.2.1 Historical Trend (2018-2024)
10.2.2 Forecast Trend (2025-2034)
10.3 Nigeria
10.3.1 Historical Trend (2018-2024)
10.3.2 Forecast Trend (2025-2034)
10.4 South Africa
10.4.1 Historical Trend (2018-2024)
10.4.2 Forecast Trend (2025-2034)
10.5 Others
11 Market Dynamics
11.1 SWOT Analysis
11.1.1 Strengths
11.1.2 Weaknesses
11.1.3 Opportunities
11.1.4 Threats
11.2 Porter’s Five Forces Analysis
11.2.1 Supplier’s Power
11.2.2 Buyer’s Power
11.2.3 Threat of New Entrants
11.2.4 Degree of Rivalry
11.2.5 Threat of Substitutes
11.3 Key Indicators for Demand
11.4 Key Indicators for Price
12 Value Chain Analysis
13 Price Analysis
14 Competitive Landscape
14.1 Supplier Selection
14.2 Key Global Players
14.3 Key Regional Players
14.4 Key Player Strategies
14.5 Company Profiles
14.5.1 NutriGold Inc.
14.5.1.1 Company Overview
14.5.1.2 Product Portfolio
14.5.1.3 Demographic Reach and Achievements
14.5.1.4 Certifications
14.5.2 Pharma Nord B.V.
14.5.2.1 Company Overview
14.5.2.2 Product Portfolio
14.5.2.3 Demographic Reach and Achievements
14.5.2.4 Certifications
14.5.3 Luhua Biomarine (Shandong) Co., Ltd.
14.5.3.1 Company Overview
14.5.3.2 Product Portfolio
14.5.3.3 Demographic Reach and Achievements
14.5.3.4 Certifications
14.5.4 Aker BioMarine ASA
14.5.4.1 Company Overview
14.5.4.2 Product Portfolio
14.5.4.3 Demographic Reach and Achievements
14.5.4.4 Certifications
14.5.5 KD Pharma Group SA
14.5.5.1 Company Overview
14.5.5.2 Product Portfolio
14.5.5.3 Demographic Reach and Achievements
14.5.5.4 Certifications
14.5.6 Nordic Naturals, Inc.
14.5.6.1 Company Overview
14.5.6.2 Product Portfolio
14.5.6.3 Demographic Reach and Achievements
14.5.6.4 Certifications
14.5.7 Others
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.